CorrespondenceTeriflunomide as precipitating factor of renal failure in a patient with relapsing-remitting multiple sclerosis and focal segmental glomerulosclerosis.
Section snippets
Disclosures
Patient's written consent was obtained.
The adverse event was reported to Authorities. The authors have nothing to disclose, including financial or other conflict interest that is related to this specific article and allied areas.
Declaration of Competing Interest
None
References (6)
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
Exp Neurol
(2014)- et al.
Teriflunomide for multiple sclerosis
Cochrane Database Syst Rev
(2016) - et al.
Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature
(2017)
There are more references available in the full text version of this article.
Cited by (0)
© 2020 Published by Elsevier B.V.